CytomX Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
CytomX Therapeutics, Inc. (CTMX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $3.75 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- CytomX Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $2.86M.
- CytomX Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $887.00K, a 26.21% decline year-over-year.
- CytomX Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $874.00K, a 160.90% increase year-over-year.
- CytomX Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$708.00K, a 737.84% decline year-over-year.
- CytomX Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $1.24M.
- CytomX Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$1.43M.
- CytomX Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$2.42M, a 175.92% decline from fiscal 2022.
- CytomX Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $3.18M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.75M 10-Q · filed 2026-08-06 | $4.62M derived: sum of 3 quarters · filed 2026-08-06 | $3.91M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $887.00K 10-Q · filed 2026-05-07 | $1.76M derived: sum of 2 quarters · filed 2026-05-07 | $1.05M derived: sum of 3 quarters · filed 2026-05-07 | $927.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $874.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $166.00K derived: sum of 2 quarters · filed 2026-03-16 | $40.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.24M 10-K · filed 2026-03-16 | |||
| 2025-09-30 | -$708.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$834.00K derived: sum of 2 quarters · filed 2026-08-06 | $368.00K 10-Q · filed 2025-11-06 | $703.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.08M 10-Q · filed 2026-08-06 | $1.41M derived: sum of 3 quarters · filed 2026-08-06 | $1.52M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $1.20M 10-Q · filed 2026-05-07 | $1.54M derived: sum of 2 quarters · filed 2026-05-07 | $1.65M derived: sum of 3 quarters · filed 2026-05-07 | $981.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $446.00K derived: sum of 2 quarters · filed 2026-03-16 | -$221.00K derived: sum of 3 quarters · filed 2026-03-16 | -$1.43M 10-K · filed 2026-03-16 | |||
| 2024-09-30 | $111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$556.00K derived: sum of 2 quarters · filed 2025-11-06 | -$1.77M 10-Q · filed 2025-11-06 | -$1.45M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | -$667.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.88M 10-Q · filed 2025-08-07 | -$1.56M derived: sum of 3 quarters · filed 2025-08-07 | -$1.93M derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | -$1.21M 10-Q · filed 2025-05-12 | -$895.00K derived: sum of 2 quarters · filed 2025-05-12 | -$1.26M derived: sum of 3 quarters · filed 2025-05-12 | -$2.85M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$53.00K derived: sum of 2 quarters · filed 2025-03-06 | -$1.63M derived: sum of 3 quarters · filed 2025-03-06 | -$2.42M 10-K · filed 2025-03-06 | -$2.47M 10-K · filed 2024-03-11 | ||
| 2023-09-30 | -$370.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.95M derived: sum of 2 quarters · filed 2024-11-07 | -$2.73M 10-Q · filed 2024-11-07 | -$2.79M 10-Q · filed 2023-11-07 | $456.00K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | -$1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$2.36M 10-Q · filed 2024-08-08 | -$2.43M 10-Q · filed 2023-08-08 | $826.00K derived: sum of 3 quarters · filed 2024-08-08 | $125.00K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$781.00K 10-Q · filed 2024-05-08 | $2.41M derived: sum of 2 quarters · filed 2024-05-08 | $1.71M derived: sum of 3 quarters · filed 2024-05-08 | $1.79M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $2.49M derived: sum of 2 quarters · filed 2024-03-11 | $2.57M derived: sum of 3 quarters · filed 2024-03-11 | $3.18M 10-K · filed 2024-03-11 | |||
| 2022-09-30 | -$701.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$620.00K derived: sum of 2 quarters · filed 2023-11-07 | -$7.00K 10-Q · filed 2023-11-07 | $456.00K derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | $81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $694.00K 10-Q · filed 2023-08-08 | -$694.00K 10-Q · filed 2022-08-04 | $1.16M derived: sum of 3 quarters · filed 2023-08-08 | $1.08M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $613.00K 10-Q · filed 2023-05-09 | $1.08M derived: sum of 2 quarters · filed 2023-05-09 | $1.00M derived: sum of 3 quarters · filed 2023-05-09 | -$558.00K derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $463.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | $388.00K derived: sum of 2 quarters · filed 2023-03-27 | -$1.17M derived: sum of 3 quarters · filed 2023-03-27 | -$2.81M 10-K/A · filed 2023-03-27 | |||
| 2021-09-30 | -$75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.63M derived: sum of 2 quarters · filed 2022-11-08 | -$3.27M 10-Q · filed 2022-11-08 | -$14.86M derived: sum of 4 quarters · filed 2023-03-27 | |||
| 2021-06-30 | -$1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$3.20M 10-Q · filed 2022-08-04 | -$14.79M derived: sum of 3 quarters · filed 2023-03-27 | -$16.06M derived: sum of 4 quarters · filed 2023-03-27 | |||
| 2021-03-31 | -$1.64M 10-Q · filed 2022-05-05 | -$13.23M derived: sum of 2 quarters · filed 2023-03-27 | -$14.50M derived: sum of 3 quarters · filed 2023-03-27 | -$16.68M derived: sum of 4 quarters · filed 2023-03-27 | |||
| 2020-12-31 | -$11.59M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | -$12.86M derived: sum of 2 quarters · filed 2023-03-27 | -$15.04M derived: sum of 3 quarters · filed 2023-03-27 | -$81.00K 10-K/A · filed 2023-03-27 | |||
| 2020-09-30 | -$1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$3.45M derived: sum of 2 quarters · filed 2021-11-04 | $11.51M 10-Q · filed 2021-11-04 | $9.63M derived: sum of 4 quarters · filed 2023-03-27 | |||
| 2020-06-30 | -$2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $12.78M 10-Q · filed 2021-08-05 | $10.90M derived: sum of 3 quarters · filed 2023-03-27 | $12.43M derived: sum of 4 quarters · filed 2023-03-27 | |||
| 2020-03-31 | $14.96M 10-Q · filed 2021-05-06 | $13.08M derived: sum of 2 quarters · filed 2023-03-27 | $14.60M derived: sum of 3 quarters · filed 2023-03-27 | $13.70M derived: sum of 4 quarters · filed 2023-03-27 | |||
| 2019-12-31 | -$1.88M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | -$354.00K derived: sum of 2 quarters · filed 2023-03-27 | -$1.26M derived: sum of 3 quarters · filed 2023-03-27 | -$2.07M 10-K/A · filed 2023-03-27 | |||
| 2019-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $621.00K derived: sum of 2 quarters · filed 2020-08-06 | -$193.00K 10-Q · filed 2019-11-07 | $1.17M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | -$906.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.72M 10-Q · filed 2020-08-06 | -$359.00K derived: sum of 3 quarters · filed 2021-02-24 | $1.30M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | -$814.00K 10-Q · filed 2020-05-07 | $547.00K derived: sum of 2 quarters · filed 2021-02-24 | $2.21M derived: sum of 3 quarters · filed 2021-02-24 | $2.96M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $3.02M derived: sum of 2 quarters · filed 2021-02-24 | $3.78M derived: sum of 3 quarters · filed 2021-02-24 | $4.90M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.42M derived: sum of 2 quarters · filed 2019-11-07 | $3.54M 10-Q · filed 2019-11-07 | $3.04M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-06-30 | $756.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.88M 10-Q · filed 2019-08-07 | $1.38M derived: sum of 3 quarters · filed 2020-02-27 | $1.65M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-03-31 | $1.12M 10-Q · filed 2019-05-09 | $626.00K derived: sum of 2 quarters · filed 2020-02-27 | $895.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.36M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2017-12-31 | -$496.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$227.00K derived: sum of 2 quarters · filed 2020-02-27 | $234.00K derived: sum of 3 quarters · filed 2020-02-27 | $456.00K 10-K · filed 2020-02-27 | |||
| 2017-09-30 | $269.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $730.00K derived: sum of 2 quarters · filed 2018-11-06 | $952.00K 10-Q · filed 2018-11-06 | $447.00K derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-06-30 | $461.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $683.00K 10-Q · filed 2018-08-08 | $178.00K derived: sum of 3 quarters · filed 2019-02-27 | $1.17M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-03-31 | $222.00K 10-Q · filed 2018-05-09 | -$283.00K derived: sum of 2 quarters · filed 2019-02-27 | $707.00K derived: sum of 3 quarters · filed 2019-02-27 | $680.00K derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2016-12-31 | -$505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $485.00K derived: sum of 2 quarters · filed 2019-02-27 | $458.00K derived: sum of 3 quarters · filed 2019-02-27 | $1.60M 10-K · filed 2019-02-27 | |||
| 2016-09-30 | $990.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $963.00K derived: sum of 2 quarters · filed 2017-11-07 | $2.10M 10-Q · filed 2017-11-07 | $3.20M derived: sum of 4 quarters · filed 2018-03-07 | |||
| 2016-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $1.11M 10-Q · filed 2017-08-07 | $2.21M derived: sum of 3 quarters · filed 2018-03-07 | $1.92M derived: sum of 4 quarters · filed 2018-03-07 | |||
| 2016-03-31 | $1.14M 10-Q · filed 2017-05-05 | $2.23M derived: sum of 2 quarters · filed 2018-03-07 | $1.95M derived: sum of 3 quarters · filed 2018-03-07 | $2.22M derived: sum of 4 quarters · filed 2018-03-07 | |||
| 2015-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $812.00K derived: sum of 2 quarters · filed 2018-03-07 | $1.08M derived: sum of 3 quarters · filed 2018-03-07 | $1.49M 10-K · filed 2018-03-07 | |||
| 2015-09-30 | -$283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$14.00K derived: sum of 2 quarters · filed 2016-11-03 | $396.00K 10-Q · filed 2016-11-03 | -$220.00K derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2015-06-30 | $269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $679.00K 10-Q · filed 2016-08-03 | $63.00K derived: sum of 3 quarters · filed 2017-03-02 | ||||
| 2015-03-31 | $410.00K 10-Q · filed 2016-05-06 | -$206.00K derived: sum of 2 quarters · filed 2017-03-02 | |||||
| 2014-12-31 | -$616.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $261.00K 10-K · filed 2017-03-02 | |||||
| 2014-09-30 | $877.00K 10-Q · filed 2015-11-23 | ||||||
| 2013-12-31 | $88.00K 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |